Imaging cognitive impairment and impulse control disorders in Parkinson's disease

Dementia and mild forms of cognitive impairment as well as neuropsychiatric symptoms (i. e., impulse control disorders) are frequent and disabling non-motor symptoms of Parkinson's disease (PD). The identification of changes in neuroimaging studies for the early diagnosis and monitoring of...

Descripción completa

Detalles Bibliográficos
Autores: Martín-Bastida, Antonio, Delgado-Alvarado, Manuel, Navalpotro-Gómez, Irene, Rodríguez-Oroz, María C.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/53888
Acceso en línea:http://hdl.handle.net/10230/53888
http://dx.doi.org/10.3389/fneur.2021.733570
Access Level:acceso abierto
Palabra clave:Parkinson&apos
s disease dementia (PDD)
Impulse control disorders (ICD)
Magnetic resonance imaging (MRI)
Mild cognitive impairment (MCI)
Positron emission tomography (PET)
Single photon computed tomography (SPECT)
Descripción
Sumario:Dementia and mild forms of cognitive impairment as well as neuropsychiatric symptoms (i. e., impulse control disorders) are frequent and disabling non-motor symptoms of Parkinson's disease (PD). The identification of changes in neuroimaging studies for the early diagnosis and monitoring of the cognitive and neuropsychiatric symptoms associated with Parkinson's disease, as well as their pathophysiological understanding, are critical for the development of an optimal therapeutic approach. In the current literature review, we present an update on the latest structural and functional neuroimaging findings, including high magnetic field resonance and radionuclide imaging, assessing cognitive dysfunction and impulse control disorders in PD.